サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1413136

次世代乳がん診断・スクリーニング市場：製品、診断技術、スクリーニング技術、用途、エンドユーザー別-2024～2030年の世界予測

Next-Generation Breast Cancer Diagnostic & Screening Market by Product, Diagnostic Technology, Screening Technology, Application, End User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 192 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
次世代乳がん診断・スクリーニング市場：製品、診断技術、スクリーニング技術、用途、エンドユーザー別-2024～2030年の世界予測
出版日: 2024年01月15日
発行: 360iResearch
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

次世代乳がん診断・スクリーニング市場規模は2023年に41億4,000万米ドルと推計され、2024年には45億7,000万米ドルに達し、CAGR 11.13%で2030年には86億8,000万米ドルに達すると予測されます。

次世代乳がん診断・スクリーニングの世界市場

主な市場の統計
基準年[2023］ 41億4,000万米ドル
予測年[2024］ 45億7,000万米ドル
予測年 [2030] 86億8,000万米ドル
CAGR（%） 11.13%
Next-Generation Breast Cancer Diagnostic &Screening Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは次世代乳がん診断・スクリーニング市場を評価する上で極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、次世代乳がん診断・スクリーニング市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-次世代乳がん診断・スクリーニング市場の市場規模および予測は？

2-次世代乳がん診断・スクリーニング市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-次世代乳がん診断・スクリーニング市場における技術動向と規制の枠組みは？

4-次世代乳がん診断・スクリーニング市場における主要ベンダーの市場シェアは？

5-次世代乳がん診断・スクリーニング市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で乳がんの罹患率が上昇
      • 病気の早期診断と治療への傾向
      • 乳がんに関する意識を高める政府の取り組み
    • 抑制要因
      • 乳がんの診断およびスクリーニング技術の製造コストが高い
    • 機会
      • 次世代乳がん診断・スクリーニングテクノロジーの進歩
      • 革新的なパンがん診断ソリューションを製造するための戦略的提携と投資
    • 課題
      • 製造の複雑さと厳格な規制承認プロセス
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 次世代乳がん診断・スクリーニング市場：製品別

  • アクセサリー
  • 乳房画像診断システム
  • ソフトウェアとサービス

第7章 次世代乳がん診断・スクリーニング市場診断技術別

  • DNAマイクロアレイ
  • ラボオンチップ &逆転写PCR
  • 分子診断学
  • 次世代シーケンス
  • タンパク質マイクロアレイ
  • qPCRと多重化

第8章 次世代乳がん診断・スクリーニング市場スクリーニング技術別

  • イオン化乳房画像化技術
    • 3D乳房トモシンセシス
    • アナログマンモグラフィー
    • コーンビームコンピュータ断層撮影法（CBCT）
    • 造影マンモグラフィー（CEM）
    • 全視野デジタルマンモグラフィー（FFDM）
    • 乳房分子イメージング/乳房特異的ガンマイメージング（MBI/BSGI）
    • 陽電子放射マンモグラフィー（PEM）
    • 陽電子放出断層撮影法およびコンピュータ断層撮影法（PET-CT）
  • 非電離乳房画像技術
    • 自動全乳房超音波検査（AWBU）
    • 乳房MRI
    • 乳房サーモグラフィー
    • 乳房超音波検査
    • 電気インピーダンス断層撮影法
    • 光学イメージング

第9章 次世代乳がん診断・スクリーニング市場：用途別

  • がん検診
  • コンパニオン診断
  • リスク分析
  • 治療モニタリング

第10章 次世代乳がん診断・スクリーニング市場：エンドユーザー別

  • ブレストケアセンター
  • 画像診断センター
  • 病院とクリニック

第11章 南北アメリカの次世代乳がん診断・スクリーニング市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域の次世代乳がん診断・スクリーニング市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカの次世代乳がん診断・スクリーニング市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第15章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • Abbott Laboratories
    • Agendia Inc.
    • Agilent Technologies, Inc.
    • ARTIVION INC.
    • Becton, Dickinson and Company
    • Benitec Biopharma Ltd
    • BGI Genomics Co., Ltd.
    • Bio-Rad Laboratories, Inc.
    • Centogene N.V.
    • Danaher Corporation
    • Epic Sciences, Inc.
    • Exact Sciences Corporation
    • F. Hoffmann-La Roche Ltd.
    • Fujifilm Holdings Corporation
    • GE HealthCare Technologies, Inc.
    • Hologic, Inc.
    • Illumina, Inc.
    • Invivoscribe, Inc.
    • Koninklijke Philips N.V.
    • Laboratory Corporation of America Holdings
    • Merck & Co., Inc.
    • Myriad Genetics, Inc.
    • Novartis AG
    • Pfizer Inc.
    • QIAGEN N.V.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
  • 主要な製品ポートフォリオ

第16章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET RESEARCH PROCESS
  • FIGURE 2. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET DYNAMICS
  • FIGURE 7. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 12. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 26. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY BREAST IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 10. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DNA MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY LAB-ON-A-CHIP & REVERSE TRANSCRIPTASE-PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PROTEIN MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY QPCR & MULTIPLEXING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 17. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 19. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY 3D BREAST TOMOSYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ANALOG MAMMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY CONE-BEAM COMPUTED TOMOGRAPHY (CBCT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY CONTRAST-ENHANCED MAMMOGRAPHY (CEM), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY FULL-FIELD DIGITAL MAMMOGRAPHY (FFDM), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING/BREAST SPECIFIC GAMMA IMAGING (MBI/BSGI), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY POSITRON EMISSION MAMMOGRAPHY (PEM), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 29. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY AUTOMATED WHOLE-BREAST ULTRASOUND (AWBU), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY BREAST MRI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY BREAST THERMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY BREAST ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY ELECTRIC IMPEDANCE TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY CANCER SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY RISK ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY THERAPEUTIC MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY BREAST CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. PHILIPPINES NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 149. SINGAPORE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 150. SINGAPORE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. SINGAPORE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH KOREA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH KOREA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 163. TAIWAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 164. TAIWAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. TAIWAN NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 170. THAILAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 171. THAILAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. THAILAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 177. VIETNAM NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 178. VIETNAM NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. VIETNAM NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 192. DENMARK NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 193. DENMARK NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. DENMARK NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 199. EGYPT NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 200. EGYPT NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. EGYPT NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 206. FINLAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 207. FINLAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. FINLAND NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 213. FRANCE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 214. FRANCE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. FRANCE NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 220. GERMANY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 221. GERMANY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. GERMANY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 227. ISRAEL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 228. ISRAEL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. ISRAEL NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 234. ITALY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 235. ITALY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. ITALY NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY DIAGNOSTIC TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY SCREENING TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
  • TABLE 242. NETHERLANDS NEXT-GENERATION BREAST CANCER DIAGNOSTIC & SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. NETHER
目次
Product Code: MRR-5C6F41F5B007

[192 Pages Report] The Next-Generation Breast Cancer Diagnostic & Screening Market size was estimated at USD 4.14 billion in 2023 and expected to reach USD 4.57 billion in 2024, at a CAGR 11.13% to reach USD 8.68 billion by 2030.

Global Next-Generation Breast Cancer Diagnostic & Screening Market

KEY MARKET STATISTICS
Base Year [2023] USD 4.14 billion
Estimated Year [2024] USD 4.57 billion
Forecast Year [2030] USD 8.68 billion
CAGR (%) 11.13%
Next-Generation Breast Cancer Diagnostic & Screening Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Next-Generation Breast Cancer Diagnostic & Screening Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Next-Generation Breast Cancer Diagnostic & Screening Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Next-Generation Breast Cancer Diagnostic & Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agendia Inc., Agilent Technologies, Inc., ARTIVION INC., Becton, Dickinson and Company, Benitec Biopharma Ltd, BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Centogene N.V., Danaher Corporation, Epic Sciences, Inc., Exact Sciences Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., Hologic, Inc., Illumina, Inc., Invivoscribe, Inc., Koninklijke Philips N.V., Laboratory Corporation of America Holdings, Merck & Co., Inc., Myriad Genetics, Inc., Novartis AG, Pfizer Inc., QIAGEN N.V., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Next-Generation Breast Cancer Diagnostic & Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Accessories
    • Breast Imaging Systems
    • Software & Services
  • Diagnostic Technology
    • DNA Microarrays
    • Lab-on-a-Chip & Reverse Transcriptase-PCR
    • Molecular Diagnostics
    • Next Generation Sequencing
    • Protein Microarrays
    • qPCR & Multiplexing
  • Screening Technology
    • Ionizing Breast Imaging Technologies
      • 3D Breast Tomosynthesis
      • Analog Mammography
      • Cone-Beam Computed Tomography (CBCT)
      • Contrast-Enhanced Mammography (CEM)
      • Full-Field Digital Mammography (FFDM)
      • Molecular Breast Imaging/Breast Specific Gamma Imaging (MBI/BSGI)
      • Positron Emission Mammography (PEM)
      • Positron Emission Tomography and Computed Tomography (PET-CT)
    • Non-ionizing Breast Imaging Technologies
      • Automated Whole-Breast Ultrasound (AWBU)
      • Breast MRI
      • Breast Thermography
      • Breast Ultrasound
      • Electric Impedance Tomography
      • Optical Imaging
  • Application
    • Cancer Screening
    • Companion Diagnostics
    • Risk Analysis
    • Therapeutic Monitoring
  • End User
    • Breast Care Centers
    • Diagnostic Imaging Centers
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Next-Generation Breast Cancer Diagnostic & Screening Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Next-Generation Breast Cancer Diagnostic & Screening Market?

3. What are the technology trends and regulatory frameworks in the Next-Generation Breast Cancer Diagnostic & Screening Market?

4. What is the market share of the leading vendors in the Next-Generation Breast Cancer Diagnostic & Screening Market?

5. Which modes and strategic moves are suitable for entering the Next-Generation Breast Cancer Diagnostic & Screening Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Next-Generation Breast Cancer Diagnostic & Screening Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of breast cancer worldwide
      • 5.1.1.2. Inclination towards early diagnosis and treatment of diseases
      • 5.1.1.3. Government initiatives to raise awareness regarding breast cancer
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of manufacturing of breast cancer diagnostic & screening technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in next-generation breast cancer diagnostic & screening technologies
      • 5.1.3.2. Strategic alliances and investments to manufacture innovative bread cancer diagnostic solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Complexity in manufacturing and stringent regulatory approval process
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Next-Generation Breast Cancer Diagnostic & Screening Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. Breast Imaging Systems
  • 6.4. Software & Services

7. Next-Generation Breast Cancer Diagnostic & Screening Market, by Diagnostic Technology

  • 7.1. Introduction
  • 7.2. DNA Microarrays
  • 7.3. Lab-on-a-Chip & Reverse Transcriptase-PCR
  • 7.4. Molecular Diagnostics
  • 7.5. Next Generation Sequencing
  • 7.6. Protein Microarrays
  • 7.7. qPCR & Multiplexing

8. Next-Generation Breast Cancer Diagnostic & Screening Market, by Screening Technology

  • 8.1. Introduction
  • 8.2. Ionizing Breast Imaging Technologies
    • 8.3.1. 3D Breast Tomosynthesis
    • 8.3.2. Analog Mammography
    • 8.3.3. Cone-Beam Computed Tomography (CBCT)
    • 8.3.4. Contrast-Enhanced Mammography (CEM)
    • 8.3.5. Full-Field Digital Mammography (FFDM)
    • 8.3.6. Molecular Breast Imaging/Breast Specific Gamma Imaging (MBI/BSGI)
    • 8.3.7. Positron Emission Mammography (PEM)
    • 8.3.8. Positron Emission Tomography and Computed Tomography (PET-CT)
  • 8.3. Non-ionizing Breast Imaging Technologies
    • 8.4.1. Automated Whole-Breast Ultrasound (AWBU)
    • 8.4.2. Breast MRI
    • 8.4.3. Breast Thermography
    • 8.4.4. Breast Ultrasound
    • 8.4.5. Electric Impedance Tomography
    • 8.4.6. Optical Imaging

9. Next-Generation Breast Cancer Diagnostic & Screening Market, by Application

  • 9.1. Introduction
  • 9.2. Cancer Screening
  • 9.3. Companion Diagnostics
  • 9.4. Risk Analysis
  • 9.5. Therapeutic Monitoring

10. Next-Generation Breast Cancer Diagnostic & Screening Market, by End User

  • 10.1. Introduction
  • 10.2. Breast Care Centers
  • 10.3. Diagnostic Imaging Centers
  • 10.4. Hospitals & Clinics

11. Americas Next-Generation Breast Cancer Diagnostic & Screening Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Next-Generation Breast Cancer Diagnostic & Screening Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Next-Generation Breast Cancer Diagnostic & Screening Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. Competitive Portfolio

  • 15.1. Key Company Profiles
    • 15.1.1. Abbott Laboratories
    • 15.1.2. Agendia Inc.
    • 15.1.3. Agilent Technologies, Inc.
    • 15.1.4. ARTIVION INC.
    • 15.1.5. Becton, Dickinson and Company
    • 15.1.6. Benitec Biopharma Ltd
    • 15.1.7. BGI Genomics Co., Ltd.
    • 15.1.8. Bio-Rad Laboratories, Inc.
    • 15.1.9. Centogene N.V.
    • 15.1.10. Danaher Corporation
    • 15.1.11. Epic Sciences, Inc.
    • 15.1.12. Exact Sciences Corporation
    • 15.1.13. F. Hoffmann-La Roche Ltd.
    • 15.1.14. Fujifilm Holdings Corporation
    • 15.1.15. GE HealthCare Technologies, Inc.
    • 15.1.16. Hologic, Inc.
    • 15.1.17. Illumina, Inc.
    • 15.1.18. Invivoscribe, Inc.
    • 15.1.19. Koninklijke Philips N.V.
    • 15.1.20. Laboratory Corporation of America Holdings
    • 15.1.21. Merck & Co., Inc.
    • 15.1.22. Myriad Genetics, Inc.
    • 15.1.23. Novartis AG
    • 15.1.24. Pfizer Inc.
    • 15.1.25. QIAGEN N.V.
    • 15.1.26. Siemens Healthineers AG
    • 15.1.27. Thermo Fisher Scientific Inc.
  • 15.2. Key Product Portfolio

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing